Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Molnupiravir Emergency use authorization Experimental Antiviral Jun/23/2022 17 1
mRNA-1273 Emergency use authorization Experimental Vaccine Jun/22/2022 26 1
Ivermectin Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/30/2022 17 3
Baricitinib Emergency use authorization Used to treat other disease Other treatment Feb/03/2022 33 2
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Jan/04/2022 16 1
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Epigallocatechin Gallate Potential treatment - pre-clinical evidence Natural product Antiviral Apr/08/2021 11 0
Cyclosporine Potential treatment - clinical evidence Used to treat other disease Other treatment Mar/23/2021 7 0
Famotidine Potential treatment - clinical evidence Used to treat other disease Unknown Mar/08/2021 2 3
RBD nanoparticle vaccine Potential treatment - pre-clinical evidence Experimental Vaccine Feb/12/2021 2 0